◀ Back to MAPK3
MAPK3 — PTK2B
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Pandey et al., J Biol Chem 1999
:
Overexpression of
RAFTK leads to the activation of p38
MAPK ... We observe that the dominant negative mutant of MKK3 but not of MKK6, SEK1, or MEK1 inhibits
RAFTK induced p38
MAPK activity
Kumar et al., J Biol Chem 1999
:
Overexpression of
RAFTK induces activation of c-Jun amino-terminal kinase ( also known as stress activated protein kinase ),
mitogen activated protein kinase ( MAPK ), and p38 MAPK ... Furthermore, in contrast to the phosphatase-dead SHPTP1 C453S mutant, overexpression of wild-type SHPTP1 blocks interaction of RAFTK with the SH2-domain of c-Src and inhibits
RAFTK mediated
MAPK activation
Couty et al., Biol Cell 2004
(Disease Models, Animal...) :
In in vitro systems, HHV-8-GPCR signals via multiple transduction pathways including, activation of phospholipase C and PKC, inhibition of adenylyl cyclase, activation of nuclear factor-kappaB ; activation PI 3-kinase,
p42/44 MAPK and Akt/PKB, and
activation of JNK/SAPK, p38 MAPK and
RAFTK
Hatch et al., Blood 1998
(Leukemia, Monocytic, Acute) :
Inhibition of
RAFTK by a dominant negative kinase mutant
reduced CSF-1/M-CSF induced
MAPK activity